HTRA2 and cancer: All these facts lead to the assumption that HtrA2 could be a novel target in cancer therapy (reviewed by Chien et al. 2009; Żurawa-Janicka et al. 2010) or in the therapy of neurodegenerative disorders (reviewed by Bhuiyan and Fukunaga 2009).